Tech Company Financing Transactions

Beta Bionics Funding Round

On 1/11/2019, Beta Bionics announced $63 million in Series B investment from Eventide Asset Management, ArrowMark Partners and Dexcom.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

8 Saint Mary's St. 936
Boston, MA 02215
USA

Phone

Undisclosed

Website

www.betabionics.com

Email Address

Not Recorded

Overview

Beta Bionics is proud to be a Massachusetts public benefit corporation. We believe we are one of the first, if not the first medical device company to be doing business as a benefit corporation, and we're fairly certain that Beta Bionics is the first company to do so in the diabetes space.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Edward Damiano

        

Vice President

Firas El-Khatib

        

VP - Bus. Development

Ed Raskin

        

VP - General Counsel

Serafina Raskin

        

VP - Operations

David Henderson

        

VP - R & D

Michael Rosinko

        

Browse more venture capital transactions:

Prev: 1/11/2019: Infinitum Electric venture capital transaction
Next: 1/11/2019: Postmates venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary